154 related articles for article (PubMed ID: 10575919)
1. [Aplastic anemia--contemporary procedures and therapeutic perspectives].
Zawirska D; Skotnicki AB
Przegl Lek; 1999; 56(7-8):506-14. PubMed ID: 10575919
[TBL] [Abstract][Full Text] [Related]
2. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
[TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
4. Unrelated donor marrow transplantation for severe aplastic anaemia.
Howard MR
Transfus Sci; 1991; 12(3):123-34. PubMed ID: 10149542
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of severe acquired aplastic anemia].
Jacobsen N
Nord Med; 1995; 110(12):314-5. PubMed ID: 8524632
[TBL] [Abstract][Full Text] [Related]
6. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
[TBL] [Abstract][Full Text] [Related]
7. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group.
Bacigalupo A
Eur J Haematol Suppl; 1996; 60():16-9. PubMed ID: 8987236
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow aplasia].
Fiandino G; Gabutti V; Messina M; Branca R; Fortina P; Ramenghi U; Saracco P; Miniero R
Pediatr Med Chir; 1986; 8(1):3-8. PubMed ID: 3523446
[TBL] [Abstract][Full Text] [Related]
9. [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia].
Mrsić M; Seiwerth RS; Labar B; Bogdanić V; Nemet D; Duraković N; Mikulić M; Sertić D; Aurer I; Radman I; Zupancić-Salek S
Acta Med Croatica; 2009 Jun; 63(3):209-14. PubMed ID: 19827347
[TBL] [Abstract][Full Text] [Related]
10. [Aplastic anemia].
Speck B
Schweiz Med Wochenschr; 1986 Oct; 116(43):1467-74. PubMed ID: 3538378
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.
Passweg JR; Pérez WS; Eapen M; Camitta BM; Gluckman E; Hinterberger W; Hows JM; Marsh JC; Pasquini R; Schrezenmeier H; Socié G; Zhang MJ; Bredeson C
Bone Marrow Transplant; 2006 Apr; 37(7):641-9. PubMed ID: 16489361
[TBL] [Abstract][Full Text] [Related]
12. [Severe aplastic anemia].
Hinterberger W
Wien Med Wochenschr; 1991; 141(9-10):205-8. PubMed ID: 1949845
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies for patients with severe aplastic anemia.
Bacigalupo A
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S42-S44. PubMed ID: 18724299
[TBL] [Abstract][Full Text] [Related]
14. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
[TBL] [Abstract][Full Text] [Related]
15. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
Arranz R; Conde E; Rodriguez-Salvanés F; Pajuelo FJ; Cabrera R; Sanz MA; Petit J; Bueno J; Maldonado J; Odriozola J; Conde JG; Brunet S; Carreras E; Iriondo A; Fernández-Rañada JM; Marín P;
Bone Marrow Transplant; 2002 Feb; 29(3):205-11. PubMed ID: 11859392
[TBL] [Abstract][Full Text] [Related]
16. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.
Kim SY; Lee JW; Lim J; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Kim CC
Biol Blood Marrow Transplant; 2007 Jul; 13(7):863-70. PubMed ID: 17580265
[TBL] [Abstract][Full Text] [Related]
17. [Allogenic hematopoietic stem cell transplantation in acquired aplastic anemia: first experience of the National Center for Bone Marrow Grafting].
Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A
Tunis Med; 2001 Oct; 79(10):498-502. PubMed ID: 11910688
[TBL] [Abstract][Full Text] [Related]
18. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
[TBL] [Abstract][Full Text] [Related]
20. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
Bunin N; Aplenc R; Iannone R; Leahey A; Grupp S; Monos D; Pierson G
Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
